185
primaryand recurrentpterygia.Ophthalmology2001;108:985-988.
23.
Bradley JC, Yang W, Bradley RC, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol
2010;94:815-820.
24.
Torres J, Enríquez-de-SalamancaA, Fernández I, Rodríguez-AresMT, QuadradoMJ,Murta J, Benítez
delCastillo JM,SternME,CalongeM.ActivationofMAPKsignalingpathwayandNF-kappaBactivation
in pterygium and ipsilateral pterygium-free conjunctival specimens. Invest Ophthalmol Vis Sci.
2011;52:5842-5852.
25.
DiGirolamoN,KumarRK,CoroneoMTUVB-mediated inductionof interleukin-6and -8 inpterygiaand
culturedhumanpterygiumepithelial cells. InvestOphthalmolVisSci 2002;43:3430-3437.
26.
Kria L, OhiraA, Amemiya T. Growth factors in culturedpterygiumfibroblasts: immunohistochemical
andELISAanalysis.GraefesArchClinExpOphthalmol 1998;236:702-708.
27.
Wang IJ, Hu FR, ChenPJ, LinCT.Mechanismof abnormal elastin geneexpression in thepinguecular
partofpterygia.Am JPathol 2000;157:1269-1276.
28.
ReidTW,DushkuN.Doeshumanpapillomaviruscausepterygium?Br JOphthalmol.2003;87:806-808.
29.
Di Girolamo N. Association of human papilloma virus with pterygia and ocular-surface squamous
neoplasia. Eye (Lond).2012;26:202-11.
30.
Donaldson KE, Alfonso EC. Recent advances in pterygium excision. Contemporary Ophthalmology
2003;2(25):1-8.
31.
HisrtLW. The treatmentofpterygium. SurvOphthalmol 2003;48:145-180.
32.
Sanchez-ThorinJC,RochaG,YelinJB.Meta-analysisontherecurrenceratesafterbarescleraressection
with and without mitomycin C use and conjunctival autograft placement in surgery for primary
pterigium.Br JOphthalmol 1998;82:661-668.
33.
Bahar I, Kaiserman I, Lange AP, Slomovic A, Levinger E, SansanayudhW, Slomovic AR. The effect of
mitomycinConcorneal endothelium inpterygiumsurgery.Am JOphthalmol 2009;147:447-452.
34.
Kheirkhah A, Izadi A, Kiarudi MY, Nazari R, Hashemian H, Behrouz MJ. Effects of mitomycin C on
corneal endothelial cell counts in pterygium surgery: role of application location. Am J Ophthalmol
2011;151:488-493.
35.
WanNorlizaWN,Raihan IS,Azwa JA, IbrahimM.Scleralmelting16yearsafterpterygiumexcisionwith
topicalmitomycinCadjuvant therapy.ContLensAntEye2006;29:165-167.
36.
Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr Opin
Ophthalmol.2007;18:308-313.
37.
Khakshoor H, Razavi ME, Daneshvar R, Shakeri MT, Ghate MF, Ghooshkhanehi H. Preoperative
Subpterygeal InjectionVs IntraoperativeMitomycinC forPterygiumRemoval: Comparisonof Results
andComplications.Am JOphthalmol 2010;150:193-198.
38.
Donnenfeld ED, Perry HD, Fromer S, Doshi S, Solomon R, Biser S. Subconjunctival mitomycin C as
adjunctive therapybeforepterygiumexcision.Ophthalmology2003;110:1012-1016.
39.
Avisar R, Bar S, Weinberger D. Preoperative injection of mitomycin C in combined pterygium and
cataract surgery.Cornea2005;24:406-409.
40.
Akinci A, Zilelioglu O. Comparison of limbal-conjunctival autograft and intraoperative 0.02%
mitomycin-C for treatmentofprimarypterygium. IntOphthalmol 2007;27:281-285.
41.
Panda A, Das GK, Tuli SW, Kumar A. Randomized trial of intraoperativemitomycin C in surgery for
pterygium.Am JOphthalmol 1998;125:59-63.
42.
Frucht-Pery J, RaiskupF, IlsarM, LandauD,OrucovF, SolomonA. Conjunctival autograftingcombined
with low-dose mitomycin C for prevention of primary pterygium recurrence. Am J Ophthalmol
2006;141:1044-1050.
43.
Ari S, Caca I, Yildiz ZO, Sakalar YB, Dogan E. Comparison of mitomycin C and limbal-conjunctival
autograft in thepreventionof pterygial recurrence inTurkishpatients: aone-year, assessor-masked,
